Microsoft and Drug Discovery: Collaborative Molecular Environment (C-ME)

Microsoft Expands Life Sciences Effort. ‘ Microsoft said Thursday it has struck agreements with several life sciences and software companies to develop and distribute software to help researchers create new drugs. Microsoft said it reached a deal with IO Informatics, a maker of software for pharmaceutical and biotechnology companies, to commercialize prototype software for visualizing molecules and appending notes and data to the images. The software, called “Collaborative Molecular Environment,” was written by InterKnowlogy, a contract software developer that builds products and prototypes for Microsoft. The app lets scientists annotate molecular images with notes, spreadsheets, or links to published research. Scientists can access the system over the Web and search their annotations for key phrases. The software takes advantage of graphics technology in Windows Vista and the SharePoint Server collaboration software.’

Channel 9: The Scripps Research Institute’s Collaborative Molecular Environment. ‘Collaboration Molecular Environment (C-ME) uses WPF, WinForms, and Office 2007 to front end Sharepoint 2007. In this video Dr. Peter Kuhn from TSRI and Tim Huckaby from Interknowlogy show us a demo of C-ME, talk about its origins and the impact it is having on how they operate.’

BioIT Alliance Community Server. ‘The Alliance is a group of organizations working together to realize the potential of personalized medicine. The Alliance unites the pharmaceutical, biotech, hardware, and software industries to explore new ways to share complex biomedical data and collaborate among multi-disciplinary teams to speed the pace of discovery in the life sciences.’

Microsoft Press Releases:

  1. Microsoft Forms BioIT Alliance With Life Science Industry Leaders to Help Accelerate Pace of Drug Discovery and Development. ‘Founding members including Accelrys Software, Affymetrix, Amylin Pharmaceuticals, Applied Biosystems and The Scripps Research Institute share common goal of creating a stronger link between technology and science.’
  2. BioIT Alliance Shows Progress in Accelerating the Pace of Drug Discovery and Development. ‘Agilent Technologies, Applied Biosystems and Illumina Inc. team up with Microsoft and software providers to accelerate work in biomarker discovery.’
  3. New Alliance of Technology Companies and Research Organizations Seeks to Personalize Medicine. ‘More than 35 companies are working with Microsoft to further integrate science and technology in ways that help researchers make personalized medicine a reality.’

Speak Your Mind